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Background: The myocardial performance (Tei) index is a simple, reproducible and easily performed measure of cardiac 
performance. Its ease of use and proven clinical application make this an attractive measure perioperatively. For appropriate use 
of this index under sevoflurane anaesthesia, drug effects on normal values need to be defined.
Methods: A total of 38 ASA 1 patients were consecutively included in this study. Induction was by sevoflurane inhalation. 
Steady state was defined as 3–5 min spontaneous tidal ventilation with an end-tidal sevoflurane concentration of at least 2.3%. 
Baseline and steady-state measurements included haemodynamics and four-chamber transthoracic echocardiographic image 
acquisition. Offline analysis focused on tissue Doppler studies of the lateral mitral annulus. Discrete variables before and after 
induction were compared.
Results: Changes in simple haemodynamic variables were as expected (Systolic blood pressure: mean [95% CI] –11.62 [–15.96 to 
–7.27]; diastolic blood pressure: mean [95% CI] –6.46 [–11.65 to –1.28]; heart rate: mean [95% CI] 2.66 [–1.72 to 7.05]). Isovolumic 
contraction time decreased from baseline (mean [95% CI] –3.37 [–5.11 to –1.64]). Isovolumic relaxation time also decreased 
(mean [95% CI] –7.44 [–10.23 to –4.66]). Ejection time decreased (mean [95% CI] –4.41 [–11.62 to 2.80]). This saw a consistent 
decrease in the Tei index with a p-value of < 0.0001 (mean [95% CI] –0.035 [–0.050 to –0.021]).
Conclusion: Sevoflurane at 1-MAC minimally decreases the Tei index. This implies that, overall, myocardial mechanics/
performance in healthy individuals is not negatively affected by sevoflurane anaesthesia. Reference values for this index appear 
to be applicable for patients under sevoflurane anaesthesia.
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Introduction
Echocardiography has become indispensable in the perioperative 
setting.1 The Myocardial Performance (Tei) index offers a reliable 
measure of overall cardiac function in normal and pathological 
states.2–5 It is said to be independent of both haemodynamic and 
loading alterations2, 3,6–9 although this is frequently questioned.10 
Nevertheless, it could be an attractive perioperative gauge as it is 
perceived as relatively easy to measure and is reproducible in a 
number of clinical situations.5
The Tei index incorporates systolic and diastolic function into a 
single numeric value and correlates well with conventional 
haemodynamic measures of these,11, 12 with some suggestion 
that it may be superior.13, 14 It is a time interval index conventionally 
derived using pulsed-wave Doppler interrogation of trans-mitral 
inflow and left ventricular outflow using the equation Tei = 
(IVCT+IVRT)/ET, where IVCT is the isovolumic contraction time 
and IVRT is the isovolumic relaxation time.2 A tissue Doppler 
imaging (TDI) derived alternative has the added benefit of single 
cardiac cycle interrogation and correlates well with the 
conventional method (Figure 1).15,16 The mean normal value of 
the Tei index for the left ventricle is 0.39 ± 0.05.2
There is evidence to suggest that acute changes to preload alter 
the Tei index.5,10,17–19 This may purely be a normal physiological 
response to preload changes which the index is tracking, and 
could prove useful when evaluating preload optimisation in 
vivo.9 The debate over the clinical usefulness of the Tei index is 
largely centred on this contradiction.10
Sevoflurane is widely used, is relatively cardiac stable and 
appears to offer pharmacological preconditioning.19–23 It is 
thought to be negatively inotropic through its effects on calcium 
homeostasis, but at clinically relevant doses this does not appear 
to affect simple haemodynamics.20 It has been shown to improve 
diastolic dysfunction.23–26 The effect of sevoflurane on the Tei 
index has not yet been studied. There is global consensus that 
echocardiographic parameters may need to be redefined for the 
anaesthetised patient.27
This study tested the null hypothesis that sevoflurane, 
administered at clinically relevant doses, does not affect overall 
cardiac function when assessed using the Tei index. This was 
tested in spontaneously breathing healthy individuals. As a 
secondary outcome, applicability of normal Tei index values 
under sevoflurane anaesthesia was explored.
Methods
This study was approved by the Ethics Committee of the Faculty 
of Health Sciences, University of the Free State, Bloemfontein, 
South Africa (ECUFS NR 55/2013). Institutional approval was 
obtained to consecutively enrol male and female American 
Society of Anesthesiologists (ASA) 1 patients scheduled for 
elective surgery at the local Academic Hospital. All participants 
gave written, informed consent.
Inclusion criteria were: age 18–50  years; ASA 1 status; effort 
tolerance > 4 METS (metabolic equivalents of task) as assessed 
with the Duke activity index; and a normal preoperative 
cardiopulmonary clinical examination. Exclusion criteria 
comprised: any need for haemodynamic support or positive 
pressure airway manoeuvres for airway obstruction; any need for 
mechanical ventilatory support; abnormal baseline Tei index; 
pregnancy; and intellectual disability. Patients were all examined 
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by the principal investigator (ACK) and no pre-medication was 
prescribed. Patients were allowed to opt for pre-medication and 
if they chose this they were excluded from the study.
On arrival in theatre intravenous access was secured and baseline 
pulse oximetry, three-lead electrocardiogram and non-invasive 
blood pressure were recorded (Datex-Ohmeda, GE, Helsinki, 
Finland). Baseline echocardiographic images were captured 
before induction.
Patients received an inhalational induction using sevoflurane 
(SojournTM, Safeline Pharmaceuticals (Pty) Ltd) at 4–6% in 40% 
oxygen and air. Airway support consisted of chin-lift and jaw-
thrust manoeuvres only. Supraglottic airway device (SGA) 
placement was performed when the steady-state concentration 
of sevoflurane was achieved. Steady-state concentration was 
defined as an end-tidal sevoflurane concentration of 2.3% for 
3–5 min with spontaneous tidal volume breathing. Spontaneous 
breathing with no mechanical assistance was maintained 
throughout. Once the SGA was placed, all haemodynamic and 
echocardiographic measurements were repeated. The duration 
of the steady-state assessment was minimised and end tidal 
carbon dioxide, measured using standard side stream 
capnography, did not increase above 45  mmHg before 
conclusion. No other drugs were administered. At the end of 
data collection the anaesthetic and surgery proceeded as 
planned by the attending team.
All echocardiographic assessments were made using a Vivid S6 
(General Electric Healthcare Systems, Helsinki, Finland) 
sonographic workstation. A transthoracic protocol was followed 
using a 3.6–1.5  MHz cardiac probe with simultaneous ECG 
monitoring. Using the standard apical four-chamber view, tissue 
Doppler imaging (TDI) of the lateral mitral annulus was 
performed. Patients were kept in an identical supine position 
pre- and post-induction.
Comprehensive off-line echocardiographic analysis allowed us to 
measure the isovolumic contraction time (IVCT), the isovolumic 
relaxation time (IVRT) and the ejection time (ET). The s’-wave 
duration was used as a surrogate for ET.15,16 The duration between 
the end of the a’-wave and the following E’-wave was also recorded, 
as well as the E’ velocity. (Figure 2). The Tei index was derived using 
the alternative TDI-derived method described earlier.15, 16
Continuous variables were presented as mean values and 
standard deviations. Differences between pre- and post-
induction variables were reported as 95% confidence intervals. 
The paired t-test was applied and differences with a p-value 
of < 0.05 were regarded as statistically significant. All statistical 
analysis was done by the Department of Biostatistics, University 
of the Free State, Bloemfontein, South Africa using the SAS® 9.3 
software package (SAS Institute, Cary, IN, USA).
Results
Thirty-eight patients were enrolled, with the first two acting as a 
demonstration of the imaging protocol to be used. They were 
excluded from the final data-set. Further exclusions are outlined 
in Figure 3. The patients excluded for airway obstruction relate to 
patients who required any positive pressure airway intervention 
during induction but before steady state was achieved, at which 
time an SGA device would be placed. Three patients had 
abnormal Tei-index measurements at baseline and were 
excluded from the trial as this study aimed to investigate only 
normal hearts. The final data-set consisted of 27 patients. 
Demographic data are summarised in Table 1. Haemodynamic 
and echocardiographic findings are summarised in Table 2.
Discussion
The current study attempted to define the effect of sevoflurane 
on the Tei index. As a secondary outcome we examined whether 
accepted normal values are potentially applicable under 
sevoflurane anaesthesia. Patients were healthy and expected to 
maintain basic cardiopulmonary homeostasis as gauged by 
haemodynamic measures, capnography and oxygen saturation. 
Any intervention in this regard resulted in exclusion. No other 
drugs were administered and only sevoflurane was used to 
induce anaesthesia. Once data collection was complete, the 
attending anaesthetist continued with his/her planned 
anaesthetic technique. It was felt that, in terms of the application 
of the Tei index, this population was a representative sample.
This study showed a consistent decrease in the Tei index 
calculated using the TDI method.15,16 The mean Tei index value at 
baseline was normal for patients included in this study (0.40) and 
had a narrow confidence interval. When considering the ways in 
which sevoflurane could influence the Tei index, it is best to 
consider each of the components that make up the index 
separately. These are described by the original formula for 
calculating the Tei index: TEI = (IVCT+IVRT)/ET.2, 3
Figure 1: (A) The original Doppler-derived Tei index showing the E and 
a waves of transmitral inflow, ejection time (ET) as measured in the left 
ventricular outflow tract. Isovolumic contraction (IVCT) and relaxation 
(IVRT) times are indicated. (B) The tissue Doppler derived alternative 
showing the E’, a’ and s waves typical of lateral mitral annular motion. 
Again the isovolumic contraction and relaxation times are shown.
Figure 2: Tissue Doppler imaging of the lateral mitral annulus.
Notes: A represents the duration from the a’ wave to the subsequent E’ wave, 
with B representing the S wave duration, used as a surrogate of the ejection 
time.
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carbon dioxide, measured using standard side stream 
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sonographic workstation. A transthoracic protocol was followed 
using a 3.6–1.5  MHz cardiac probe with simultaneous ECG 
monitoring. Using the standard apical four-chamber view, tissue 
Doppler imaging (TDI) of the lateral mitral annulus was 
performed. Patients were kept in an identical supine position 
pre- and post-induction.
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Continuous variables were presented as mean values and 
standard deviations. Differences between pre- and post-
induction variables were reported as 95% confidence intervals. 
The paired t-test was applied and differences with a p-value 
of < 0.05 were regarded as statistically significant. All statistical 
analysis was done by the Department of Biostatistics, University 
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software package (SAS Institute, Cary, IN, USA).
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demonstration of the imaging protocol to be used. They were 
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and echocardiographic findings are summarised in Table 2.
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Figure 1: (A) The original Doppler-derived Tei index showing the E and 
a waves of transmitral inflow, ejection time (ET) as measured in the left 
ventricular outflow tract. Isovolumic contraction (IVCT) and relaxation 
(IVRT) times are indicated. (B) The tissue Doppler derived alternative 
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Figure 2: Tissue Doppler imaging of the lateral mitral annulus.
Notes: A represents the duration from the a’ wave to the subsequent E’ wave, 
with B representing the S wave duration, used as a surrogate of the ejection 
time.
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Isovolumic contraction time (IVCT) is defined as the period 
between atrioventricular (AV) valve closure and ventriculoarterial 
(VA) valve opening.28 This study demonstrated a statistically 
significant decrement of the IVCT (–3.37; p-value 0.0005). 
Isovolumic relaxation time (IVRT) is defined as the period 
between VA-valve closure and AV-valve opening.28 The reduction 
in the IVRT was also significant in this study (–7.44, p-value < 
0.0001) and this correlates well with previous work studying 
patients under anaesthesia, breathing spontaneously.23,25,27 The 
mechanisms for the changes observed could potentially be due 
to the effects sevoflurane has on conductive tissue and therefore 
electromechanical coupling.29–33 Sevoflurane’s effects on 
conduction and contractility are traditionally thought to be 
negative, and would therefore be expected to prolong time-
interval indices. The fact that this study showed shorter 
isovolumic times suggests that it is more likely explained by 
haemodynamic changes across the valves.
Delayed mitral valve closure and/or expedited aortic valve 
opening would explain the shorter IVCT. Mitral valve closure 
occurs when left atrial pressure (LAP) is surpassed by left 
ventricular pressure.28 Conventionally, left atrial pressure is 
expected to be lowered by sevoflurane due to the drug’s effect 
on atrial preload.20 Recent echocardiographic evidence shows 
minimal changes to left atrial reservoir function during 
sevoflurane anaesthesia while breathing spontaneously,34 
suggesting minimal changes to LAP in this setting. Previous work 
has shown that late ventricular filling may be slightly impaired, 
indicating a negative inotropic effect on atrial systole.23,24,26 This 
could potentially translate into a higher than expected LAP at 
end diastole, causing delayed mitral valve closure. Sevoflurane 
has been shown to negatively influence dP/dT(max) during 
systole, implying a negative inotropic effect.33 Recent 
echocardiographic evidence in patients under sevoflurane 
anaesthesia, using clinically relevant doses, points to the 
contrary.23,25 A smaller than expected effect on the inotropic state 
of the left ventricle, coupled with a lowered aortic diastolic blood 
pressure, would explain earlier aortic valve opening. The change 
in IVCT illustrated by this study is likely due to a combination of 
factors, which appear to include loading changes across the 
valves. This brings the load independency of the Tei index into 
question again.5
Delayed closure of the aortic valve and/or earlier opening of the 
mitral valve will shorten the IVRT. Sevoflurane is known to 
decrease systemic vascular resistance (SVR) in a dose-dependent 
manner.20 This could cause a greater pressure discrepancy 
between the left ventricle and the aorta during early diastole, 
delaying aortic valve closure. Improved early diastolic function 
has been suggested under sevoflurane anaesthesia.23,26 Various 
potential explanations have been offered and it is thought that 
altered myocardial calcium homeostasis is likely to be 
implicated.23,26 There is, however, conflicting evidence. 
Specifically, previous work by Bolliger et al. has shown a 
consistent decrease in the E’ velocity under sevoflurane 
anaesthesia in healthy individuals during spontaneous 
respiration.25 This echocardiographic measure of diastolic 
function correlates well with the rate of relaxation (–dP/dT), also 
known as Tau.25,35 The present study showed a slight decrease in 
E’ velocity, which was not statistically significant (–0.17, p-value = 
0.671). An enhanced rate of relaxation would explain earlier 
ventricular and atrial pressure approximation during diastole, 
resulting in expedited mitral valve opening. The change in 
loading conditions across the mitral and aortic valves, therefore, 
appears to be the likely cause for the reduction in the IVRT 
illustrated in this study.
The duration of the s’-wave was accepted as a surrogate for the 
ejection time (ET) during this study.15,16 The study shows a minor 
decrease with poor clinical and statistical significance (–4.41, 
p-value  =  0.22). Seminal work on the determinants of the ET 
revealed that heart rate was the major determinant of the period, 
with stroke index and loading conditions playing relatively minor 
roles.36 The heart rate findings in the present study showed a 
minor difference which was not significant (2.67, p-value = 0.223). 
This study showed a consistent decrease in the duration between 
the a’-wave and the E’-wave which is statistically significant 
(–17.37, p-value = 0.0024). It is this difference, an important part 
of the numerator for the Tei index ratio,2,3,15,16 which appears to 
explain the overall change in the index. This finding also 
Total study population
n = 38
Final data set 
n = 27
Exclusions (n = 11):
•  Pilot patients (n = 2)
•  Airway obstruction (n = 4)
•  Inadequate images (n = 2)
•  Abnormal Tei (n = 3) 
Figure 3: Study population.
Table 1: Demographic data
Item Data
Age (mean) 31
Gender Male 26% (n = 7)
Female 74% (n = 20)
Ethnicity White 22% (n = 6)
Black 74% (n = 20)
Other 4% (n = 1)
Table 2: Pre- and post-induction variables
Notes: bpm = beats per minute; SBP (mmHg) = systolic blood pressure in 
millimetres of mercury; DBP (mmHg) = diastolic blood pressure in millimetres 
of mercury; IVCT (ms) = isovolumic contraction time in milliseconds; IVRT (ms) = 
isovolumic relaxation time in milliseconds; s’-wave duration (ms) = ejection time in 









79; 11.82 81; 13.63 2.67; −1.72 to 7.06; 0.223
SBP (mmHg) 124; 15.61 112; 16.50 −11.62; −15.96 to −7.27;  
< 0.0001
DBP (mmHg) 73; 11.02 67; 11.49 −6.46; −11.65 to −1.28; 0.017
IVCT (ms) 39.26; 6.04 35.89; 6.36 −3.37; −5.11 to −1.64; 0.0005




282.37; 25.48 277.96; 20.58 −4.41; −11.62 to 2.8; 0.22
E’-velocity 
(cm.s–1)
15.21, 2.60 15.04; 2.66 −0.17; −0.98 to 0.64; 0.671
Tei index 0.40;0.02 0.36; 0.04 −0.04; −0.05 to −0.02;  
< 0.0001
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measurements were encountered these scans were all reviewed. 
Studies not fit for accurate assessment were excluded from the 
final data-set. The principal investigator was responsible for 
data analysis and this was therefore not blinded, which is 
another potential source of bias. An effort to minimise this was 
made by random review of technique by an experienced 
echocardiographer (JvdW).
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underlines the important part changes to the IVCT and IVRT have 
to play in affecting the Tei index under sevoflurane anaesthesia.
The incidental finding that our study population had IVCT and 
IVRT values that differed slightly from accepted normal values 
cannot be explained by this study. These differences are very 
small, especially when considering that normal IVCT is 30 ms and 
IVRT 70 ± 12 ms. Our data show time indices that overlap with 
values accepted as normal. The mean Tei index value was normal. 
This implies that the ratio of the various time indices remained 
normal for our population. Correlations between time indices 
and race, age and physical status could be grounds for further 
research and will not be discussed here.
The final consideration should be how sevoflurane affects the 
‘neurohormonal loading conditions’ of the myocardium. 
Circulating catecholamines have a directly positive inotropic and 
lusitropic effect.28 Sevoflurane used for rapid induction of general 
anaesthesia has been shown to decrease blood pressure and 
adrenaline levels but increase noradrenaline levels.37,38 This is 
similar to what is seen during maintenance of anaesthesia after 
rapid dose increases of sevoflurane.39 Sevoflurane therefore 
appears to attenuate the sympathetic response to a reduced SVR, 
responding only with an increase in circulating noradrenaline. 
Noradrenaline affects the myocardium directly, but this effect is 
likely not significant when compared with adrenaline.28 
Neurohormonal responses to sevoflurane are, therefore, less 
likely to explain the changes seen to the IVCT and IVRT.
The manner in which clinical doses of sevoflurane affect the Tei 
index in healthy individuals is likely of negligible clinical 
relevance, but is statistically significant (–0.03, p-value < 0.0001). 
The change observed in the Tei index would imply that overall 
cardiac function is not negatively influenced by clinically useful 
doses of sevoflurane in this population, when breathing 
spontaneously. This study lacks the power that a large 
epidemiological study would have had on stating whether the 
accepted normal values are applicable under anaesthesia, but 
the statistical significance of the finding allows us to make the 
supposition that they are. The load independency of the index is, 
however, again brought into question. Further research, 
investigating the effects of sevoflurane on this index in patients 
with cardiovascular disease, could deepen our understanding of 
how the drug interferes with cardiovascular mechanics with a 
compromised substrate. The effects of other anaesthetic drugs 
and intermittent positive pressure ventilation need to be 
investigated to make these findings clinically applicable. It is 
hoped that this study will serve as a useful reference point.
The Tei index remains an attractive, easy to use perioperative 
measure and the relatively small changes to the value caused by 
sevoflurane should encourage its application.
Study limitations
The present study population is small but compares well with 
previous work using a similar study design examining similar 
echocardiographic parameters.23,25,26 For this reason a power 
analysis was excluded. Demographic data reveal a study 
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